LONDON—A company specializing in treating cat, grass and dust-mite allergies is planning to float an offering on the London Stock Exchange, a move that people familiar with the situation said is aimed at raising £175 million ($285 million), which would rank as one of the biggest U.K. biotech listings ever.. The company, Circassia, said it is aiming to sell a stake of between 25% and 40%. The float will be predominantly new shares and will be used to fund future product and clinical trials. The company has raised £105 million...
  